Amantadine: Difference between revisions
No edit summary |
|||
| Line 16: | Line 16: | ||
''' [[Amantadine description|Description]]''' | ''' [[Amantadine description|Description]]''' | ||
'''| [[Amantadine clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Amantadine clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Amantadine indications and usage|Indications and Usage]]''' | '''| [[Amantadine indications and usage|Indications and Usage]]''' | ||
'''| [[Amantadine contraindications|Contraindications]]''' | '''| [[Amantadine contraindications|Contraindications]]''' | ||
| Line 23: | Line 22: | ||
'''| [[Amantadine drug interactions|Drug Interactions]]''' | '''| [[Amantadine drug interactions|Drug Interactions]]''' | ||
'''| [[Amantadine overdosage|Overdosage]]''' | '''| [[Amantadine overdosage|Overdosage]]''' | ||
'''| [[Amantadine dosage and administration|Dosage and Administration]]''' | '''| [[Amantadine dosage and administration|Dosage and Administration]]''' | ||
'''| [[Amantadine how supplied|How Supplied]]''' | '''| [[Amantadine how supplied|How Supplied]]''' | ||
Revision as of 15:47, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Amantadine (1-aminoadamantane, sold as Symmetrel) is an antiviral drug used both as an antiviral and an antiparkinsonic.
Category
Antiviral
US Brand Names
Symadine®, Symmetrel®
FDA Package Insert
Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
Antiviral The mechanism by which amantadine exerts its antiviral activity is not clearly understood. It appears to mainly prevent the release of infectious viral nucleic acid into the host cell by interfering with the function of the transmembrane domain of the viral M2 protein. In certain cases, amantadine is also known to prevent virus assembly during virus replication. It does not appear to interfere with the immunogenicity of inactivated influenza A virus vaccine.